Agilent/Dako

CD 274, Programmed cell death 1 ligand 1 (B7-H1)

#M3653 · western blot

56
Citing papers
905
Combined citations
Supplier page Find this product

Research areas

Cancer Immunotherapy and Biomarkers33Immunotherapy and Immune Responses8Cancer Genomics and Diagnostics7Ovarian cancer diagnosis and treatment5Cancer, Stress, Anesthesia, and Immune Response4Cancer Cells and Metastasis4Lung Cancer Treatments and Mutations4Pancreatic and Hepatic Oncology Research4

Papers citing this product

1
Role of PD-L1 Expression in Non-Small Cell Lung Cancer and Their Prognostic Significance according to Clinicopathological Factors and Diagnostic Markers
International Journal of Molecular Sciences·2019·200 cit.·DOI
2
First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients
Journal of Nuclear Medicine·2021·129 cit.·DOI
3
The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
Nature Communications·2022·82 cit.·DOI
4
<scp><i>NTRK</i></scp> fusion positive colorectal cancer is a unique subset of <scp>CRC</scp> with high <scp>TMB</scp> and microsatellite instability
Cancer Medicine·2022·65 cit.·DOI
5
PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients
Oncotarget·2017·51 cit.·DOI
6
Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China
Frontiers in Oncology·2021·38 cit.·DOI
7
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)
European Journal of Cancer·2023·35 cit.·DOI
8
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)
Cell Reports Medicine·2024·31 cit.·DOI
9
Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in triple negative breast cancer patients
Archives of Gynecology and Obstetrics·2022·23 cit.·DOI
10
Endoscopic calcium electroporation for colorectal cancer: a phase I study
Endoscopy International Open·2023·21 cit.·DOI

Similar products

ProductVendorPricePapers
CD 274, Programmed cell death 1 ligand 1 (B7-H1)Spring Bioscience—13
CD 274, Programmed cell death 1 ligand 1 (B7-H1) — Evidence — PubIndex